Fortified CBD oil for treatment of PTSD

ABSTRACT

A liquid capsule of cannabis, ginseng, and turmeric rhizome oil blend consisting essentially of an oil blend of cannabis oil, turmeric rhizome oil, and ginseng oil in a liquid capsule. There is less than 4 ppm of tetrahydrocannabinol (THC) in the oil blend.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 16/510,160filed Jul. 12, 2019, which claims priority to U.S. ProvisionalApplication No. 62/696,913, which was filed on Jul. 12, 2018, and isincorporated herein by reference.

BACKGROUND

This application relates to Cannabidiol (CBD) oil, and more particularlyto a blended CBD oil for the treatment of stress-related healthconditions, such as posttraumatic stress disorder (PTSD).

PTSD is a disorder that develops in some people who have experienced ashocking, scary, or dangerous event. Such events trigger manysplit-second changes in the body to help defend against danger or toavoid it. In many cases, people recover from initial symptoms after afew days or weeks. This is called acute stress disorder, or “ASD.” Thosewho continue to experience the symptoms which last more than a month andseriously affect one's ability to function, and are not due to substanceuse, medical illness, or anything except the event itself, might besuffering from PTSD.

One can develop PTSD at any age. This includes war veterans, children,and people who have been through a physical or sexual assault, abuse,accident, disaster, climatic changes resulting in storms, hurricanes andother natural calamities, surgery, hospitalization, war, or many otherserious events. The most prescribed medications for treating PTSDinclude antidepressants, sleep medications, and relaxants.

SUMMARY

An example blended oil composition includes a combination of Cannabidiol(CBD) oil extracted from Cannabis sativa, curcumin oil including one ormore curcuminoids from turmeric rhizomes, and ginsenoside oil includingone or more ginsenosides from at least one of Panax ginseng and P.quinquefolius, wherein the Cannabis sativa comprises at least one of C.sativa, C. indica, and C. ruderalis.

An example method of producing CBD oil includes extracting CBD oil fromCannabis sativa, wherein the Cannabis sativa comprises at least one ofC. sativa, C. indica, and C. ruderalis; obtaining curcumin oil includingone or more curcuminoids from turmeric rhizomes; obtaining ginsenosideoil from including one or more ginsenosides from at least one of Panaxginseng and P. quinquefolius; and blending the CBD, curcumin, andginsenosides in a blended oil composition.

The embodiments, examples, and alternatives of the preceding paragraphs,the claims, or the following description and drawings, including any oftheir various aspects or respective individual features, may be takenindependently or in any combination. Features described in connectionwith one embodiment are applicable to all embodiments, unless suchfeatures are incompatible.

DETAILED DESCRIPTION

The present disclosure describes a unique blend of Cannabis CBD oil,turmeric oil, and ginseng oil. In particular, the CBD oil is fortifiedwith at least one curcuminoid from turmeric and at least one ginsenosidefrom Panax ginseng and/or P. quinquefolius. The blended CBD oilcomposition can be used for treating PTSD as well as otherstress-related health conditions, for example. Each of these threeingredients are well-suited for treating PTSD and other stress relatedconditions since all three have anti-inflammatory, calming, andmemory-enhancing properties, and as such, they are able to address thevarious manifestations of the syndrome.

In the unique formulations discussed herein, each of these threeingredients complements the pharmacology of the others, exhibiting asynergistic effect.

In one example, the blended oil composition includes less than 4 ppm ofpsychoactive tetrahydrocannabinol (THC). In a further example, theblended oil composition is free of THC.

The blended oil could be administered by prescription by authorizedregistered licensed physicians for treating PTSD and other stressrelated health conditions, for example.

The blended oil composition includes a combination of CBD, one or morecurcuminoids (e.g., curcumin), and one or more ginsenosides. The CBD isobtained from extracts of Cannabis sativa, including at least one of C.sativa, C. indica, and C. ruderalis including its subspecies, varieties,strains, and biotypes. The CBD is fortified with the curcuminoid(s) fromturmeric rhizomes, and ginsenoside(s) from at least one of Panax ginsengand P. quinquefolius. All three of the ingredients are combined to forma synergistic formulation.

The Cannabis plant extracts may be obtained from C. sativa, C. indicaand C. ruderalis and/or any of their many sub species, strains, hybridsand biotypes grown in semi-automated, computerized greenhouses.Similarly, the Curcuminoids and ginsenosides from turmeric and ginsengcan be purified from organically grown plants.

In the composition of some embodiments, the CBD oil contains a range ofcannabinoids ranging from 2.5 mg-20 mg/ml and is fortified with not lessthan 250 mg/ml of Curcuminoids and 250 mg/ml of ginsenosides. Suchfortified CBD oil can be incorporated into various beverages, tonics,liquid capsules, and tinctures. The amount may be varied to suit theneeds of differing patients.

In one example, a liquid capsule for oral intake includes 1 ml of thefortified CBD oil. In one example, 1 ml of the fortified CBD oil isincluded in a 2 ounce dose of a liquid tonic.

One example composition is a beverage including 1 ml of the fortifiedCBD oil diluted with 8 ounces of liquid emulsion. The beverage in thisexample is fortified with a selected dosage, such as a minimum dailyrequirement of vitamins and minerals.

Although example embodiments have been disclosed, a worker of ordinaryskill in this art would recognize that certain modifications would comewithin the scope of this disclosure. For that reason, the followingclaims should be studied to determine the scope and content of thisdisclosure.

What is claimed is:
 1. A liquid capsule consisting essentially ofcannabis oil, ginseng oil, and turmeric rhizome oil, wherein the oilblend is free of tetrahydrocannabinol.
 2. The liquid capsule of claim 1,wherein the oil blend includes 2.5 mg/ml-20 mg/ml of cannabis oil, atleast 250 mg/ml of rhizome oil, and at least 20 mg/ml of ginseng oil. 3.The liquid capsule of claim 1, wherein the rhizome oil and ginseng oilare organically grown.
 4. The liquid capsule of claim 1, wherein theliquid capsule includes approximately 1 ml of the oil blend.